EFFECT OF BW12C ON OXYGEN AFFINITY OF HAEMOGLOBIN IN SICKLE-CELL DISEASE

The Lancet

Volumn 327, Issue 8485, 1986, Pages 831-834

  Keidan, A J ^a,b   White, R D ^a,b   Huehns, E R ^a,b   Franklin, I M ^a,b   Joy, M ^a,b   Stuart, J ^a,b  

^a UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^b and Wellcome Research Laboratories Beckeriham United Kingdom ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTISICKLING AGENT; VELARESOL;

ADVERSE DRUG REACTION; BLOOD AND HEMOPOIETIC SYSTEM; CLINICAL ARTICLE; DRUG EFFICACY; DRUG THERAPY; HUMAN; INFUSION; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; OXYGEN AFFINITY; PRIORITY JOURNAL; SICKLE CELL ANEMIA; THERAPY;

ADULT; ALDEHYDES; ANEMIA, SICKLE CELL; ASPARTATE AMINOTRANSFERASES; BENZALDEHYDES; BILIRUBIN; BINDING, COMPETITIVE; CLINICAL TRIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTE COUNT; ERYTHROCYTE DEFORMABILITY; HEMOGLOBIN, SICKLE; HEMOLYSIS; HUMANS; INFUSIONS, PARENTERAL; LEUKOCYTE COUNT; MALE; OXYGEN; OXYGEN CONSUMPTION; OXYHEMOGLOBINS; THALASSEMIA; TIME FACTORS;

EID: 0022569505     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(86)90941-4     Document Type: Article

References (17)

1. Treatment of sickle-cell disease
2. Hemoglobin S polymerization: primary determinant of the hemolytic and clinical severity of the sickling syndromes
3. Sickle cell disease: the proportion of liganded haemoglobin needed to prevent crises
4. Substituted benzaldehydes designed to increase the oxygen affinity of human haemoglobin and inhibit the sickling of sickle erythrocytes
5. The effects in volunteers of BW12C, a compound designed to left-shift the blood-oxygen saturation curve
6. Preservation of deformability (filterability) of sickle cells by BW12C during progressive deoxygenation
7. Red cell shapes. An illustrated classification and its rationale
8. Erythrocyte filtrability measurement by the initial flow rate method
9. Evaluation of leucocyte removal methods for studies oferythrocyte deformability
10. Fluctuating deformability of oxygenated sickle erythrocytes in the asymptomatic state and in painful crisis
11. Survey of sickle cell disease in England and Wales
12. Causes of death in sickle cell disease in Jamaica
13. Sickle cell disease and vascular occlusion-rheological aspects
14. Sickle cell anemia: molecular and cellular bases of therapeutic approaches
15. Clinical evaluation of cyanate in sickle cell anemia